THE OLIVE LABORATORY
  • Home
  • Science
    • Olive Lab Research
    • Pancreatic Cancer
    • Mouse Hospital
    • The KPC Model
    • Imaging
  • Lab Members
    • Alumni
  • Publications
  • More
    • A non-technical overview >
      • The Pancreas (Overview)
      • Pre-cancerous lesions (Overview)
      • Pancreatic Cancer (Overview)
      • Pancreatic Cancer Statistics
      • Symptoms and Diagnosis
      • Surgery for Pancreatic Cancer (Overview)
      • Drug Treatment (Overview)
      • Mouse Models (Overview)
      • Clinical Trials
    • Donate
    • Facilities >
      • ICRC Building
      • Shared Resources
      • Main Lab
      • Vevo 3100 Ultrasound
    • Join Us!
    • Oncology Precision Therapeutics Core >
      • MRI
      • Ivis Optical Imager
      • Vevo 3100 Ultrasound
      • Perkin-Elmer FX micro CT
    • Photos >
      • 10/30/19 Fall Fun
      • 6/29/18 Jaime's Last Day
      • 9/26/15 Mike's Wedding
      • 11/8/14 Carmine's Wedding
      • 7/7/14 Barbara's Temporary Goodbye Lunch
      • 4/26/13 Korean and Karaoke
      • 4/12/13 Purple Stride
      • 11/26/12 Pancreatic Cancer Awareness Week!!
      • 10/26/12 Pumpkin Carving
      • 9/5-7/2012 Olive and Kimmelman Lab Retreat
      • 7/13/12 Mid-summer BBQ
      • 3/29/12 Jennifer's Goodbye - BoardGame Night
      • 3/8/2012 Barbara's engagement celebration
      • 3/2/2012 Bowling
      • 12/18/2011 Holiday Party
      • 12/9/2011 Poker
      • 11/11/2011 Karaoke
      • 7/15/2011 Holiday Party
    • Support

Pancreatic Cancer

Picture
https://www.mayoclinic.org/diseases-conditions/pancreatic-cancer/symptoms-causes/syc-20355421

Pancreatic Ductal Adenocarcinoma

PDA is the most common malignancy of the pancreas. Pancreatic cancer is the 10th most common cancer in 2022 making up about 3.2% of all new cancer cases (1). PDA is an epithelial tumor, which is derived from the pancreatic ducts or ductules (2). A mutation in the Kras oncogene is the most common and earliest found PDA occurring in 90% of cases (2).  Approximately 60-70% of PDAC arise from the head of the pancreas, whereas 20-25% arise from the body/tail (3).
 
Pancreatic cancer has the worst survival rate of any organ site, with a median survival of less than six months and a 5-year survival rate of just 11.5% (1). It is the fourth most common cause of cancer-related mortality, responsible for an estimated 49,830 deaths in the US in 2022 (1). Several factors contribute to this poor prognosis. Most patients (85%) present with advanced disease, precluding them from the one effective intervention: surgical resection. However, even among those with locally confined disease who have surgery, the 5-year and 10-year survival rates are just 25% and 8% respectively, due to high recurrence rates (3). For the remaining 85% of patients, as well as those with recurrent disease, there are few treatments available. The national standard-of-care therapy, gemcitabine, modestly extends survival by a few weeks, but was primarily approved on the basis of improved quality-of-life indicators (4). The only other FDA approved agent for advanced PDA is Tarceva, which provides an average of just 10 days additional benefit when combined with gemcitabine. Despite over 60 clinical trials of different agents and combinations,(5) no other effective therapies have been identified.
​
1. SEER Cancer Stat Facts: Pancreatic Cancer. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/pancreas.html 
2. Stark, Alexander. Eibl, Guido. (2015). Pancreatic Ductal Adenocarcinoma. Pancreapedia: Exocrine Pancreas Knowledge Base, DOI: 10.3998/panc.2015.14
3. Modolell I, Guarner L, Malagelada JR. Vagaries of clinical presentation of pancreatic and biliary tract cancer. Ann Oncol 10 Suppl 4:82-84, 1999. PMID: 10436792.
3. H. Q. Xiong, K. Carr, J. L. Abbruzzese, Drugs 66, 1059 (2006).
4. A. Richter et al., World J Surg 27, 324 (Mar, 2003).
5. M. Tempero et al., J Clin Oncol 21, 3402 (Sep 15, 2003).
Powered by Create your own unique website with customizable templates.
  • Home
  • Science
    • Olive Lab Research
    • Pancreatic Cancer
    • Mouse Hospital
    • The KPC Model
    • Imaging
  • Lab Members
    • Alumni
  • Publications
  • More
    • A non-technical overview >
      • The Pancreas (Overview)
      • Pre-cancerous lesions (Overview)
      • Pancreatic Cancer (Overview)
      • Pancreatic Cancer Statistics
      • Symptoms and Diagnosis
      • Surgery for Pancreatic Cancer (Overview)
      • Drug Treatment (Overview)
      • Mouse Models (Overview)
      • Clinical Trials
    • Donate
    • Facilities >
      • ICRC Building
      • Shared Resources
      • Main Lab
      • Vevo 3100 Ultrasound
    • Join Us!
    • Oncology Precision Therapeutics Core >
      • MRI
      • Ivis Optical Imager
      • Vevo 3100 Ultrasound
      • Perkin-Elmer FX micro CT
    • Photos >
      • 10/30/19 Fall Fun
      • 6/29/18 Jaime's Last Day
      • 9/26/15 Mike's Wedding
      • 11/8/14 Carmine's Wedding
      • 7/7/14 Barbara's Temporary Goodbye Lunch
      • 4/26/13 Korean and Karaoke
      • 4/12/13 Purple Stride
      • 11/26/12 Pancreatic Cancer Awareness Week!!
      • 10/26/12 Pumpkin Carving
      • 9/5-7/2012 Olive and Kimmelman Lab Retreat
      • 7/13/12 Mid-summer BBQ
      • 3/29/12 Jennifer's Goodbye - BoardGame Night
      • 3/8/2012 Barbara's engagement celebration
      • 3/2/2012 Bowling
      • 12/18/2011 Holiday Party
      • 12/9/2011 Poker
      • 11/11/2011 Karaoke
      • 7/15/2011 Holiday Party
    • Support